Scott D. Grimes - Mar 22, 2022 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Mar 22, 2022
Transactions value $
$0
Form type
4
Date filed
3/24/2022, 07:54 PM
Previous filing
Mar 21, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Award $0 +1.66K +0.78% $0.00 216K Mar 24, 2022 Direct F1
holding CDLX Common Stock 53.1K Mar 22, 2022 See Footnote F2
holding CDLX Common Stock 55.8K Mar 22, 2022 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Unit Award $0 +31.2K +228.47% $0.00 44.8K Mar 22, 2022 Common Stock 31.2K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award. The shares underlying the RSU award vested immediately upon grant.
F2 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.
F3 The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F4 Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F5 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.